Table of contents
- Analysis of aged tau informs early change of tau before disease onset
- In vivo brain EVISF and their proteomes are sex-dependently modulated by AD-related pathology
- P-tau422: a novel neuropathological biomarker for detecting mild cognitive impairment of Alzheimer’s disease
- Ultrasensitive detection technology enabled AD biomarker discovery
- Genomic and serologic evaluation of Alzheimer’s disease risk factors in the etiology of glioblastoma
- From preclinical to clinical studies: Lessons learned in Alzheimer’s drug discovery
